Dr. Smathorn Thakolwiboon, MD

Dr. Thakolwiboon practices at Mayo Clinic Health System in La Crosse in La Crosse, Wisconsin, part of Mayo Clinic.

Dr. Thakolwiboon's NPI, 1619497161, was assigned on June 26, 2017. Dr. Thakolwiboon holds Wisconsin license 81956.

Dr. Thakolwiboon's primary practice is Mayo Clinic Health System in La Crosse, at 700 West Avenue South, La Crosse, WI 54601 in La Crosse County. The practice phone is (608) 785-0940.

Dr. Thakolwiboon's primary practice is Mayo Clinic Health System in La Crosse in La Crosse, Wisconsin, part of Mayo Clinic. Dr. Thakolwiboon is also affiliated with Mayo Clinic Health System in Eau Claire. The medical group on file is Mayo Clinic Health System in La Crosse. Dmand AI also links Dr. Thakolwiboon to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thakolwiboon practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Thakolwiboon's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Thakolwiboon's licenses on file in 3 states: Wisconsin, Minnesota and Texas.

CMS data shows 716 Medicare services from Dr. Thakolwiboon across 9 procedure codes in 2024, for 284 Medicare patients. Medicare paid $38,913 for them.

CMS counts 284 Medicare patients who saw Dr. Thakolwiboon in 2024. The largest group is 65 to 74, with 107 patients. 71% of them have high blood pressure, and 69% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Thakolwiboon's median patient age at 73, with 63% women.

In 2024, Dr. Thakolwiboon wrote 1,279 Medicare Part D claims for 214 patients. 89% of them were for generic drugs. CMS names the drug for 1,125 of them, across 36 drugs with 11 or more claims each, at $541,923 in total drug cost. In 2023, CMS named 40 claims across 3 drugs.

Dr. Thakolwiboon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thakolwiboon as offering telehealth.

Dmand AI links 40 papers to Dr. Thakolwiboon, published from 2014 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Autoantibodies, Multiple Sclerosis and Myelin-Oligodendrocyte Glycoprotein. Dr. Thakolwiboon has published most often in Mult Scler Relat Disord. Dr. Thakolwiboon's most frequent co-authors are Divyanshu Dubey, Sean J. Pittock, MD and Anastasia Zekeridou, MD.

CMS Open Payments shows 48 general payments to Dr. Thakolwiboon from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 61% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,565.